Nitric oxide and redox mechanisms in the immune response

被引:560
作者
Wink, David A. [1 ]
Hines, Harry B. [2 ]
Cheng, Robert Y. S. [1 ]
Switzer, Christopher H. [1 ]
Flores-Santana, Wilmarie [1 ]
Vitek, Michael P. [3 ]
Ridnour, Lisa A. [1 ]
Colton, Carol A. [3 ]
机构
[1] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA
[2] USA, Integrated Toxicol Div, Med Res Inst Infect Dis, Frederick, MD USA
[3] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA
关键词
oxidative nitrosative stress; signaling cascade; FACTOR-KAPPA-B; CYTOSOLIC PHOSPHOLIPASE A(2); OXYGEN SPECIES GENERATION; GROWTH-FACTOR BETA-1; HYDROXY-L-ARGININE; DELTA T-CELLS; REACTIVE OXYGEN; NADPH OXIDASE; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS;
D O I
10.1189/jlb.1010550
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of redox molecules, such as NO and ROS, as key mediators of immunity has recently garnered renewed interest and appreciation. To regulate immune responses, these species trigger the eradication of pathogens on the one hand and modulate immunosuppression during tissue-restoration and wound-healing processes on the other. In the acidic environment of the phagosome, a variety of RNS and ROS is produced, thereby providing a cauldron of redox chemistry, which is the first line in fighting infection. Interestingly, fluctuations in the levels of these same reactive intermediates orchestrate other phases of the immune response. NO activates specific signal transduction pathways in tumor cells, endothelial cells, and monocytes in a concentration-dependent manner. As ROS can react directly with NO-forming RNS, NO bioavailability and therefore, NO response(s) are changed. The NO/ROS balance is also important during Th1 to Th2 transition. In this review, we discuss the chemistry of NO and ROS in the context of antipathogen activity and immune regulation and also discuss similarities and differences between murine and human production of these intermediates. J. Leukoc. Biol. 89: 873-891; 2011.
引用
收藏
页码:873 / 891
页数:19
相关论文
共 252 条
[91]   Redox regulation of NF-κB activation:: Distinct redox regulation between the cytoplasm and the nucleus [J].
Kabe, Y ;
Ando, K ;
Hirao, S ;
Yoshida, M ;
Handa, H .
ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (3-4) :395-403
[92]   Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells [J].
Kaku, Y ;
Nanri, H ;
Sakimura, T ;
Ejima, K ;
Kuroiwa, A ;
Ikeda, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1356 (01) :43-52
[93]   Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. [J].
Kanayama, A ;
Inoue, J ;
Sugita-Konishi, Y ;
Shimizu, M ;
Miyamoto, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24049-24056
[94]   Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide [J].
Kaplan, SS ;
Lancaster, JR ;
Basford, RE ;
Simmons, RL .
INFECTION AND IMMUNITY, 1996, 64 (01) :69-76
[95]   Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice [J].
Karupiah, G ;
Chen, JH ;
Mahalingam, S ;
Nathan, CF ;
MacMicking, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1541-1546
[96]   The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs) [J].
Kavoosi, G. ;
Ardestani, S. K. ;
Kariminia, A. .
PARASITOLOGY, 2009, 136 (10) :1193-1199
[97]   Leishmania major:: Reactive oxygen species, and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes [J].
Kavoosi, Gholamreza ;
Ardestani, Sussan K. ;
Kariminia, Amina ;
Abolhassani, Mohssen ;
Turco, Salvatore J. .
EXPERIMENTAL PARASITOLOGY, 2006, 114 (04) :323-328
[98]   Gene therapy for restenosis [J].
Kibbe, MR ;
Billiar, TR ;
Tzeng, E .
CIRCULATION RESEARCH, 2000, 86 (08) :829-833
[99]   Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia [J].
Kibbe, MR ;
Tzeng, E ;
Gleixner, SL ;
Watkins, SC ;
Kovesdi, I ;
Lizonova, A ;
Makaroun, MS ;
Billiar, TR ;
Rhee, RY .
JOURNAL OF VASCULAR SURGERY, 2001, 34 (01) :156-165
[100]   Cytosolic phospholipase A2, lipoxygenase metabolites, and reactive oxygen species [J].
Kim, Cheolmin ;
Kim, Joo-Young ;
Kim, Jae-Hong .
BMB REPORTS, 2008, 41 (08) :555-559